Belpointe Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18,905
Closed -$1.92M 1105
2025
Q4
$1.92M Sell
18,905
-27,085
-59% -$2.18M 0.07% 234
2025
Q3
$2.52M Sell
45,990
-4,954
-10% -$248K 0.1% 179
2025
Q2
$2.71M Sell
50,944
-1,291
-2% -$65.6K 0.11% 158
2025
Q1
$2.26M Sell
52,235
-9,525
-15% -$482K 0.12% 160
2024
Q4
$3.81M Buy
61,760
+4
+0% +$249 0.23% 87
2024
Q3
$4.21M Sell
61,756
-10,081
-14% -$569K 0.25% 81
2024
Q2
$3.04M Buy
71,837
+30,592
+74% +$1.68M 0.21% 90
2024
Q1
$2.85M Buy
41,245
+19,775
+92% +$1.25M 0.21% 103
2023
Q4
$1.59M Buy
21,470
+15,877
+284% +$1.04M 0.14% 145
2023
Q3
$382K Buy
5,593
+3,092
+124% +$262K 0.04% 409
2023
Q2
$235K Sell
2,501
-82,953
-97% -$6.47M 0.02% 526
2023
Q1
$5.79M Sell
85,454
-1,923
-2% -$124K 0.31% 49
2022
Q4
$4.33M Buy
87,377
+37,981
+77% +$1.55M 0.26% 66
2022
Q3
$1.6M Buy
49,396
+45,533
+1,179% +$1.88M 0.11% 199
2022
Q2
$152K Sell
3,863
-97
-2% -$5.19K 0.01% 937
2022
Q1
$277K Buy
3,960
+780
+25% +$57K 0.02% 764
2021
Q4
$247K Buy
3,180
+1,073
+51% +$94.7K 0.02% 810
2021
Q3
$201K Buy
2,107
+107
+5% +$11.3K 0.01% 853
2021
Q2
$248K Buy
2,000
+985
+97% +$118K 0.02% 743
2021
Q1
$134K Sell
1,015
-1,463
-59% -$200K 0.01% 895
2020
Q4
$329K Sell
2,478
-220
-8% -$26.6K 0.03% 524
2020
Q3
$275K Buy
2,698
+323
+14% +$27.9K 0.03% 465
2020
Q2
$207K Buy
2,375
+227
+11% +$18.1K 0.03% 518
2020
Q1
$125K Buy
2,148
+739
+52% +$60K 0.02% 551
2019
Q4
$130K Buy
+1,409
New +$124K 0.02% 681

Other funds holding EXAS

Belpointe Asset Management's EXAS Position: Q1 2026 in Review

Belpointe Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 18,905 shares — an estimated $1.92M sold.

Belpointe Asset Management first reported a position in EXAS in Q4 2019 and held it in 25 quarters. The position peaked at $5.79M in Q1 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Belpointe Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Belpointe Asset Management sold 18,905 Exact Sciences shares in Q1 2026, an estimated $1.92M.
  • Belpointe Asset Management first reported a position in Exact Sciences in Q4 2019 and held it in 25 quarters.
  • Belpointe Asset Management's Exact Sciences position peaked at $5.79M in Q1 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Belpointe Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.